FDA Physician Survey Would Collect Info On Risk Communications
This article was originally published in The Pink Sheet Daily
Proposed survey seeks to understand when and how physicians like to receive risk information about drug products.
You may also be interested in...
The effort would be overseen by new Associate Center Director for Safety Policy & Communication Paul Seligman.
Janssen's net drug prices declined for the fourth year in a row in 2020, while list prices increased 3.8%, according to the company's drug pricing report.
The company is requesting FDA expand the antibody cocktail to include a COVID prevention claim with a lower 1,200mg dose and a subcutaneously administered formula.